Izumi N - Search Results

1

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.

Izumi N, Kumada H, Hashimoto N, Harada H, Imawari M, Zeniya M, Toda G. Izumi N, et al. Dig Dis Sci. 2001 Mar;46(3):516-23. doi: 10.1023/a:1005686829416. Dig Dis Sci. 2001. PMID: 11318525 Clinical Trial.

2

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.

Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C. Koizumi K, et al. Among authors: izumi n. Hepatology. 1995 Jul;22(1):30-5. Hepatology. 1995. PMID: 7541387

3

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. Enomoto N, et al. Among authors: izumi n. N Engl J Med. 1996 Jan 11;334(2):77-81. doi: 10.1056/NEJM199601113340203. N Engl J Med. 1996. PMID: 8531962 Free article.

4

Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.

Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, Miyake S, Nouchi T, Fujisawa K, Marumo F, Sato C. Izumi N, et al. Dig Dis Sci. 1996 May;41(5):989-94. doi: 10.1007/BF02091542. Dig Dis Sci. 1996. PMID: 8625774

5

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.

Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. Kurosaki M, et al. Among authors: izumi n. Hepatology. 1997 Mar;25(3):750-3. doi: 10.1002/hep.510250343. Hepatology. 1997. PMID: 9049230

6

Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.

Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C. Yamamoto C, et al. Among authors: izumi n. Hepatology. 1997 Dec;26(6):1616-20. doi: 10.1002/hep.510260633. Hepatology. 1997. PMID: 9398006

7

Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon.

Uchihara M, Izumi N, Sakai Y, Yauchi T, Miyake S, Sakai T, Akiba T, Marumo F, Sato C. Uchihara M, et al. Among authors: izumi n. Nephron. 1998 Sep;80(1):51-6. doi: 10.1159/000045125. Nephron. 1998. PMID: 9730703

8

Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.

Sakuma I, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Sakuma I, et al. Among authors: izumi n. J Infect Dis. 1999 Oct;180(4):1001-9. doi: 10.1086/315000. J Infect Dis. 1999. PMID: 10479124

9

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.

Murakami T, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Murakami T, et al. Among authors: izumi n. Hepatology. 1999 Oct;30(4):1045-53. doi: 10.1002/hep.510300405. Hepatology. 1999. PMID: 10498658

10

Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection.

Watanabe H, Enomoto N, Nagayama K, Izumi N, Marumo F, Sato C, Watanabe M. Watanabe H, et al. Among authors: izumi n. J Infect Dis. 2001 Apr 15;183(8):1195-203. doi: 10.1086/319674. Epub 2001 Mar 14. J Infect Dis. 2001. PMID: 11262201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

868 results

Search Page

Filters